SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-049026
Filing Date
2023-09-20
Accepted
2023-09-20 17:14:16
Documents
14
Period of Report
2023-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K gls-20230920.htm   iXBRL 8-K 75212
2 EX-10.1 gls-ex10_1.htm EX-10.1 81762
3 EX-10.2 gls-ex10_2.htm EX-10.2 73090
  Complete submission text file 0000950170-23-049026.txt   363849

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230920_pre.xml EX-101.PRE 10193
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230920_lab.xml EX-101.LAB 12409
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230920.xsd EX-101.SCH 2465
8 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230920_htm.xml XML 4356
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 231267154
SIC: 2834 Pharmaceutical Preparations